DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20190157

Knowledge, attitude and perception of suspected adverse drug reactions in consumers: a prospective observational study in a tertiary care hospital

Leeyasid Shaik, Vasundhara Krishnaiah, Girish K.

Abstract


Background: Adverse drug reactions (ADRs) are the main leading causes of hospitalization which leads to morbidity and mortality worldwide. Reporting of ADRs to national databases is necessary. To strengthen this system, consumers apart from health-care professionals have also been empowered to report any ADRs directly to the regulatory agencies. Direct and spontaneous patient or consumer reporting offers various benefits beyond pharmacovigilance (PV). Consumer reporting of ADRs has existed in several countries for decades, but in India, with the inclusion of consumer reporting of ADR, the data on the same is valuable and limited. Hence the present study is taken up. The aim of this study was to explore the knowledge, perceptions and practice of ADR reporting among consumers in KIMS hospital and research center, Bangalore.

Methods: The data was collected from Patients attending OPD’s, admitted in wards and at pharmacy in KIMS Hospital and Research Center, Bangalore. It is a cross sectional descriptive study. Study period is for six months from 1st April to 31st September 2018 and sample size is 200. A structured questionnaire in English and Kannada was used as a tool.

Results: Of the 200 patients from the surveyed, in males the knowledge scores were better when compared to females and attitude, perception scores were same (statistically not significant). Most of the patients opined for the establishment of consumer pharmacovigilance system at hospitals and local pharmacies.

Conclusions: Knowledge about ADR reporting and pharmacovigilance is less in consumers. So that there is a need to increase awareness in consumers.


Keywords


Adverse drug reaction, ADR reporting systems, Consumers, Pharmacovigilance

Full Text:

PDF

References


Information on Pharmacovigilance. World Health Organization. Available at: https://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/. Accessed 2015 May 16.

Information on Adverse Reaction. World Health Organization. Available at: http://www.who.int/ medicines/areas/quality_safety/safety_efficacy/ trainingcourses/definitions.pdf. Accessed 16 May 2015. Safety of medicines: a guide to detecting and reporting adverse drug reactions. World Health Organization, Geneva, 20;32-46.

Alshakka M, Jha N, Algefri S, Ibrahim MI, Hassali MA, Abdorabbo A, et al. Problems and challenges faced in consumer reporting of adverse drug reactions in developing countries-A case study of Yemen, Nepal and Malaysia. Indian J Pharmaceut Biol Res. 2014 Jul 1;2(3):37.

Tadesse WT, Mekonnen AB, Tesfaye WH, Tadesse YT. Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study. BMC Pharmacol Toxicol. 2014 Dec;15(1):32.

Jha N, Rathore DS, Shankar PR, Gyawali S, Alshakka M, Bhandary S. An educational intervention’s effect on healthcare professionals’ attitude towards pharmacovigilance. Australas Med J 2014;7(12):478-89.

van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K. Experiences with adverse drug reaction reporting by patients. Drug Safety. 2012 Jan 1;35(1):45-60.

Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007 Feb;63(2):148-56.

Cullen G, Kelly E, Murray FE. Patients’ knowledge of adverse reactions to current medications. Br J Clin Pharmacol. 2006 Aug;62(2):232-6.

Van Hunsel F, Passier A, Van Grootheest K. Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. Br J Clin Pharmacol. 2009 May 1;67(5):558-64.

Shrestha IB, Pathak LR. Review of National Health Policy 1991. Nepal: Ministry of Health and Population (MoHP) and NHSSP;2012. Available at: http://www.nhssp.org.np/health_policy/Review%20of%20National%20Health%20Policy%201991.pdf.

Jha N, Rathore DS, Shankar PR, Gyawali S, Alshakka M, Bhandary S. An educational intervention’s effect on healthcare professionals’ attitudes towards pharmacovigilance. Australasian Med J. 2014;7(12):478.

Xu H, Wang Y, Liu N. A hospital‐based survey of healthcare professionals in the awareness of pharmacovigilance. Pharmacoepidemiol Drug Saf. 2009 Jul;18(7):624-30.

Jarernsiripornkul N, Chaisrisawadsuk S, Chaiyakum A, Krska J. Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand. Pharmacy World Sci. 2009 Oct 1;31(5):559-64.

Roughead EE. Managing adverse drug reactions: time to get serious. Med J Australia. 2005 Mar 21;182(6):264.

Härmark L, van Hunsel F, Grundmark B. ADR Reporting by the general public: lessons learnt from the Dutch and Swedish Systems. Drug Saf. 2015 Apr;38(4):337-47.